Clinical Trials

 

Efgartigimod

AChR-negative Generalized Myasthenia Gravis (gMG)

ADAPT SERON

Phase 3 trial of IV efgartigimod for the treatment of AChR- Generalized Myasthenia Gravis (gMG).
Program: Efgartigimod

Post-COVID Postural Orthostatic Tachycardia Syndrome (PC-POTS)

Myositis (IMNM, ASyS, DM)

Bullous Pemphigoid (BP)

Empasiprubart

Multifocal Motor Neuropathy (MMN)

iMMersioN

A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy.

More information

ARGX-117

A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy
Program: ARGX-117

More information
argenx MMN study website

Post-Trial Access